drugset / Trial / NCT02946944
Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism
RandomizedParallel-groupOpen-labelTreatment
Summary
Pilot randomized study of the sidlenafil efficacy in combination with oral anticoagulants in the treatment of patients with intermediate-high risk of pulmonary embolism
Timeline
- Start
- 2016-10
- Primary completion
- 2020-10
- Completion
- 2020-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Apixaban | Small molecule | 10 mg | — |
| Subject | Sildenafil | Unknown | 30 mg | — |